Associations Between Sputum Torque Teno Virus Load and Lung Function and Disease Severity in Patients With Chronic Obstructive Pulmonary Disease

Yu Xie, Qing Xue, Weike Jiao, Jianhui Wu, Yan Yu, Lili Zhao, Yu Xu, Xinyu Deng, Guiju Fang, Yali Zheng, Zhancheng Gao, Yu Xie, Qing Xue, Weike Jiao, Jianhui Wu, Yan Yu, Lili Zhao, Yu Xu, Xinyu Deng, Guiju Fang, Yali Zheng, Zhancheng Gao

Abstract

Purpose: Viral load of Torque Teno virus (TTV) is elevated in immunosuppressed patients. The weakened immune response is typical in chronic obstructive pulmonary disease (COPD) patients. However, the relationship between TTV and COPD is still unknown. Patients and Methods: We enrolled 91 patients admitted to hospitals with acute exacerbation of COPD (AECOPD) between January 2017 and August 2017 (ClinicalTrials.gov ID, NCT03236480). Sputum samples were gathered during hospitalization and the 120-day follow-up. TTV distribution and genogroups were assessed, and the associations between viral loads and clinical parameters were analyzed. Results: TTV DNA was detected in 95.6% of COPD patients, and the viral load was nearly invariable at the stable and exacerbation states. Most TTV DNA-positive patients carried four distinct genotypes. Sputum load of TTV was positively associated with RV/TLC (r = 0.378, p = 0.030), and negatively correlated with FEV1/pre and FEV1/FVC (r = -0.484, -0.432, p = 0.011, 0.024, respectively). Neutral correlation between the TTV DNA load and COPD assessment test (CAT) scores (r = 0.258, p = 0.018) was observed. Conclusion: Sputum loads of TTV DNA could be a novel indicator for lung function and disease severity assessment in COPD patients.

Keywords: biomarker; chronic obstructive pulmonary disease; disease severity; lung function; torque teno virus.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2021 Xie, Xue, Jiao, Wu, Yu, Zhao, Xu, Deng, Fang, Zheng and Gao.

Figures

Figure 1
Figure 1
(A) Torque Teno virus (TTV) DNA log10 sputum loads at admission for 74 patients and at discharge for 85 patients. The Mann-Whitney U test was performed to compare the median values, and no remarkable differences were found between the two points (p = 0.870). (B) TTV DNA log10 sputum loads at admission, at discharge and during follow-up (22, 21, and 20 patients at 1, 2, and 3 months after discharge, respectively) in cohort B. Kruskal-Wallis test was performed to compare the median values, and no significant differences were found between the points in time (p = 0.270). Thick horizontal bars represent the median value of each point.
Figure 2
Figure 2
(A) Correlation between the Torque Teno virus (TTV) DNA load and the residual volume (RV)/total lung capacity (TLC) in 33 patients. (B,C) Correlation between the TTV DNA load and forced expiratory volume in 1 s (FEV1)/pre, FEV1/forced vital capacity (FVC) in 27 patients. The correlations between the values were assessed by the Spearman's rank test. The r and p-values are shown.
Figure 3
Figure 3
(A) Correlation between the Torque Teno virus (TTV) DNA load at discharge and the CAT scores in 84 patients. (B) TTV DNA load at discharge for 46 patients with 6 MWD < 250 m and 38 patients with 6 MWD ≥ 250 m. The correlation between the values was assessed by the Spearman's rank test. The Mann-Whitney U test was performed to compare the median values. The r and p-values are shown. Thick horizontal bars represent the median value of each point.
Figure 4
Figure 4
(A) Correlation between the Torque Teno virus (TTV) DNA load at discharge and the number of eosinophils in 85 patients. (B) TTV DNA load at admission for 14 patients with a number of eosinophils < 0.02 × 109/L and 60 patients with a number of eosinophils ≥ 0.02 × 109/L. The correlation between the values was assessed by the Spearman's rank test. The Mann-Whitney U test was performed to compare the median values. The r and p-values are shown. Thick horizontal bars represent the median value of each point.

References

    1. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. (1997) 241:92–7. 10.1006/bbrc.1997.7765
    1. Biagini P. Classification of TTV and related viruses (anelloviruses). Curr Top Microbiol Immunol. (2009) 331:21–33. 10.1007/978-3-540-70972-5_2
    1. Muljono DH, Nishizawa T, Tsuda F, Takahashi M, Okamoto H. Molecular epidemiology of TT virus (TTV) and characterization of two novel TTV genotypes in Indonesia. Arch Virol. (2001) 146:1249–66. 10.1007/s007050170089
    1. Takayama S, Yamazaki S, Matsuo S, Sugii S. Multiple infection of TT virus (TTV) with different genotypes in Japanese hemophiliacs. Biochem Biophys Res Commun. (1999) 256:208–11. 10.1006/bbrc.1999.0270
    1. Peng YH, Nishizawa T, Takahashi M, Ishikawa T, Yoshikawa A, Okamoto H. Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Arch Virol. (2002) 147:21–41. 10.1007/s705-002-8301-7
    1. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, et al. . TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. (1998) 28:839–42. 10.1002/hep.510280335
    1. Irshad M, Mandal K, Singh S, Agarwal SK. Torque teno virus infection in hemodialysis patients in North India. Int Urol Nephrol. (2010) 42:1077–83. 10.1007/s11255-009-9648-4
    1. Alzahrani AJ, Dela Cruz DM, Obeid OE, Bukhari HA, Al-Qahtani AA, Al-Ahdal MN. Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia. J Med Virol. (2009) 81:1343–7. 10.1002/jmv.21487
    1. Okamura A, Yoshioka M, Kikuta H, Kubota M, Ma X, Hayashi A, et al. . Detection of TT virus sequences in children with liver disease of unknown etiology. J Med Virol. (2000) 62:104–8. 10.1002/1096-9071(200009)62:1<104::AID-JMV16>;2-P
    1. Ninomiya M, Takahashi M, Nishizawa T, Shimosegawa T, Okamoto H. Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. J Clin Microbiol. (2008) 46:507–14. 10.1128/JCM.01703-07
    1. Bernardin F, Operskalski E, Busch M, Delwart E. Transfusion transmission of highly prevalent commensal human viruses. Transfusion. (2010) 50:2474–83. 10.1111/j.1537-2995.2010.02699.x
    1. Gorzer I, Haloschan M, Jaksch P, Klepetko W, Puchhammer-Stockl E. Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation. J Heart Lung Transplant. (2014) 33:320–3. 10.1016/j.healun.2013.12.007
    1. Frye BC, Bierbaum S, Falcone V, Kohler TC, Gasplmayr M, Hettich I, et al. . Kinetics of torque teno virus-DNA plasma load predict rejection in lung transplant recipients. Transplantation. (2019) 103:815–22. 10.1097/TP.0000000000002436
    1. Christensen JK, Eugen-Olsen J, M SL, Ullum H, Gjedde SB, Pedersen BK, et al. . Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. J Infect Dis. (2000) 181:1796–9. 10.1086/315440
    1. Maggi F, Pifferi M, Fornai C, Andreoli E, Tempestini E, Vatteroni M, et al. . TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol. (2003) 77:2418–25. 10.1128/JVI.77.4.2418-2425.2003
    1. Pifferi M, Maggi F, Di Cristofano C, Cangiotti AM, Nelli LC, Bevilacqua G, et al. . Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia. Pediatr Infect Dis J. (2008) 27:413–8. 10.1097/INF.0b013e318162a14f
    1. Pifferi M, Maggi F, Andreoli E, Lanini L, Marco ED, Fornai C, et al. . Associations between nasal torquetenovirus load and spirometric indices in children with asthma. J Infect Dis. (2005) 192:1141–8. 10.1086/444389
    1. Perotin JM, Dury S, Renois F, Deslee G, Wolak A, Duval V, et al. . Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. (2013) 85:866–73. 10.1002/jmv.23495
    1. Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in COPD: where do we stand? Mediators Inflamm. (2013) 2013:413735. 10.1155/2013/413735
    1. Xie S, Wang K, Zhang W, Xiao K, Yan P, Li Y, et al. . Immunodeficiency in patients with acute exacerbation of chronic obstructive pulmonary disease. Inflammation. (2018) 41:1582–9. 10.1007/s10753-018-0830-7
    1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. (2013) 187:347–65. 10.1164/rccm.201204-0596PP
    1. Maggi F, Andreoli E, Lanini L, Fornai C, Vatteroni M, Pistello M, et al. . Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried. J Clin Microbiol. (2005) 43:4807–10. 10.1128/JCM.43.9.4807-4810.2005
    1. Perez T, Deslee G, Burgel PR, Caillaud D, Le Rouzic O, Zysman M, et al. . Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities. Int J Chron Obstruct Pulmon Dis. (2019) 14:1399–410. 10.2147/COPD.S188412
    1. Cote CG, Casanova C, Marin JM, Lopez MV, Pinto-Plata V, de Oca MM, et al. . Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. (2008) 31:571–8. 10.1183/09031936.00104507
    1. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. (2004) 350:1005–12. 10.1056/NEJMoa021322
    1. Maggi F, Pifferi M, Tempestini E, Fornai C, Lanini L, Andreoli E, et al. . TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases. J Virol. (2003) 77:9081–3. 10.1128/JVI.77.16.9081-9083.2003
    1. Bando M, Ohno S, Oshikawa K, Takahashi M, Okamoto H, Sugiyama Y. Infection of TT virus in patients with idiopathic pulmonary fibrosis. Respir Med. (2001) 95:935–42. 10.1053/rmed.2001.1151
    1. Okamoto H, Nishizawa T, Takahashi M, Asabe S, Tsuda F, Yoshikawa A. Heterogeneous distribution of TT virus of distinct genotypes in multiple tissues from infected humans. Virology. (2001) 288:358–68. 10.1006/viro.2001.1097
    1. Beland K, Dore-Nguyen M, Gagne MJ, Patey N, Brassard J, Alvarez F, et al. . Torque Teno virus in children who underwent orthotopic liver transplantation: new insights about a common pathogen. J Infect Dis. (2014) 209:247–54. 10.1093/infdis/jit423
    1. Pinho-Nascimento CA, Leite JP, Niel C, Diniz-Mendes L. Torque teno virus in fecal samples of patients with gastroenteritis: prevalence, genogroups distribution, and viral load. J Med Virol. (2011) 83:1107–11. 10.1002/jmv.22024
    1. Hallett RL, Clewley JP, Bobet F, McKiernan PJ, Teo CG. Characterization of a highly divergent TT virus genome. J Gen Virol. (2000) 81(Pt 9):2273–9. 10.1099/0022-1317-81-9-2273
    1. Touinssi M, Gallian P, Biagini P, Attoui H, Vialettes B, Berland Y, et al. . TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load. J Clin Virol. (2001) 21:135–41. 10.1016/S1386-6532(01)00157-3
    1. Schiemann M, Puchhammer-Stockl E, Eskandary F, Kohlbeck P, Rasoul-Rockenschaub S, Heilos A, et al. . Torque teno virus load-inverse association with antibody-mediated rejection after kidney transplantation. Transplantation. (2017) 101:360–7. 10.1097/TP.0000000000001455
    1. O'Connor GT, Sparrow D, Demolles D, Dockery D, Raizenne M, Fay M, et al. . Maximal and partial expiratory flow rates in a population sample of 10- to 11-yr-old schoolchildren. Effect of volume history and relation to asthma and maternal smoking. Am J Respir Crit Care Med. (2000) 162(2 Pt 1):436–9. 10.1164/ajrccm.162.2.9906087
    1. Faul JL, Demers EA, Burke CM, Poulter LW. The reproducibility of repeat measures of airway inflammation in stable atopic asthma. Am J Respir Crit Care Med. (1999) 160(5 Pt 1):1457–61. 10.1164/ajrccm.160.5.9812027

Source: PubMed

3
S'abonner